Laboratory Testing in Telogen Effluvium
Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices.
INTRODUCTION
Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities …
Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices.
INTRODUCTION
Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities … 
Millions of patients experience unwanted facial hair, severely impacting their quality of life. Laser hair removal is often the treatment of choice, but this therapy is uncomfortable, requires multiple treatments, and risks pigmentary changes. Therefore, an effective topical therapy for reduction of unwanted hair is a valuable addition to our therapeutic repertoire. We continue our series, Therape … 
During the 2021 Skin of Color Update virtual conference, Dr. Maritza Perez opened her lecture by sharing her goal: to assess what is known about skin cancer and photoprotection in people of color. Dr. Perez is a member of the American Academy of Dermatology, who commissioned a workforce to look into this subject.
What is known about the epidemiology of keratinocyte carcinomas in people of color? … 
As 2021 draws to a close, the Journal of Drugs in Dermatology ends the year on a high note! Featuring a strong line up of editorials, original articles, and case reports, the December issue of the JDD includes topics ranging from new treatments for hyperpigmentation, tumescent anesthesia, HS, cosmeceuticals, lower extremity reconstruction, laser hair and identity in transgender men, and everyt … 